Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STB_RCT: Smoking Cessation in Pulmonary Tuberculosis
NCT01517022Phase 3Completed
- Sponsor
- AIIMS New Delhi
- Start
- Nov 2010
- Primary completion
- Sep 2016
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nicotine polacrilex in Tuberculosis (TB), Tobacco Use Disorder (TUD), sponsored by AIIMS New Delhi. Started Nov 2010; status: completed.
02
Drugs
nicotine polacrilex
03
Conditions
Tuberculosis (TB)Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT01517022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01517022.